| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/21/2000 | CA2367256A1 Surface localized colligin/hsp47 in carcinoma cells |
| 09/21/2000 | CA2367247A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease |
| 09/21/2000 | CA2367213A1 Novel antiangiogenic peptides |
| 09/21/2000 | CA2367211A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 09/21/2000 | CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366174A1 Human colon cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2366130A1 Human cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2365767A1 Angiogenesis inhibition |
| 09/21/2000 | CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
| 09/21/2000 | CA2364637A1 50 human secreted proteins |
| 09/21/2000 | CA2364635A1 47 human secreted proteins |
| 09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
| 09/21/2000 | CA2364568A1 Method for refolding molecules of polypeptides containing ig domains |
| 09/21/2000 | CA2364549A1 50 human secreted proteins |
| 09/21/2000 | CA2363022A1 49 human secreted proteins |
| 09/21/2000 | CA2361810A1 Pharmaceutical composition based on polyaromatic compounds |
| 09/21/2000 | CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/21/2000 | CA2361277A1 49 human secreted proteins |
| 09/20/2000 | EP1036798A1 Peptides having anti-cell adhesion activity |
| 09/20/2000 | EP1036327A2 Hla-e binding |
| 09/20/2000 | EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51 |
| 09/20/2000 | EP1036175A1 Human brain derived kcnq2 potassium channel |
| 09/20/2000 | EP1036168A1 Purification and microsequencing of hyaluronidase isozymes |
| 09/20/2000 | EP1036167A2 Nuclear targeting by means of streptococcal protein h |
| 09/20/2000 | EP1036162A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 09/20/2000 | EP1036093A1 Conjugates useful in the treatment of prostate cancer |
| 09/20/2000 | EP1036091A1 5t4 tumour-associated antigen for use in tumour immunotherapy |
| 09/20/2000 | EP1036086A1 Caspase-14 polypeptides |
| 09/20/2000 | EP1036072A1 Thrombin receptor antagonists |
| 09/20/2000 | EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/20/2000 | EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 09/20/2000 | EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/20/2000 | EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 09/20/2000 | EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 09/20/2000 | EP1011705A4 Conjugates targeted to the interleukin-2 receptor |
| 09/20/2000 | EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis |
| 09/20/2000 | EP0734376B1 Vitamin d amine and amide derivatives |
| 09/20/2000 | CN1267306A Cyclopeptide derivs. as adhesion inhibitors |
| 09/20/2000 | CN1267302A Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors |
| 09/20/2000 | CN1267300A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl protein transferase |
| 09/20/2000 | CN1267299A Aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 09/20/2000 | CN1267298A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl-protein transferase |
| 09/20/2000 | CN1267297A Benzo (5,6) cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 09/20/2000 | CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity |
| 09/20/2000 | CN1267294A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. for inhibition of farnesyl-protein transferase |
| 09/20/2000 | CN1267293A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. useful for inhibition of farnesyl-protein transferase |
| 09/20/2000 | CN1267292A Phenyl-substd. tricyclic inhibitors of farnesyl-protein transferase |
| 09/20/2000 | CN1267291A N-substituted urea inhibitors of farnesyl-protein transferase |
| 09/20/2000 | CN1267290A Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 09/20/2000 | CN1267289A Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors) |
| 09/20/2000 | CN1267288A Tricyclic keto amide derivs. useful as farnesyl protein transferase inhibitors |
| 09/20/2000 | CN1267214A Novel formulations of pharmacological agents, method for preparation thereof and method for use thereof |
| 09/20/2000 | CN1266850A O-substd. hydroxy coumaranone derivs as antineoplastic and antitransfer agent |
| 09/20/2000 | CN1266703A Medicine for treating liver cancer and preparing process thereof |
| 09/20/2000 | CN1266687A Application of Sichuan champion bauhinia saponin in preparing anti-tumor medicine |
| 09/20/2000 | CN1056617C Melanoma-inhibiting protein |
| 09/20/2000 | CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same |
| 09/20/2000 | CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions |
| 09/20/2000 | CN1056536C Glossy ganoderma preparation and its preparing method |
| 09/20/2000 | CN1056517C Goitre eliminating medicine |
| 09/19/2000 | US6121479 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics |
| 09/19/2000 | US6121451 Anticancer drugs |
| 09/19/2000 | US6121434 An oligonucleotide diagnostic agent; for the diagnosis and treatment of cancer, restenosis, a nd viral diseases affected by intergrins |
| 09/19/2000 | US6121375 Gels formed by the interaction of poly(aldehyde) with various substances |
| 09/19/2000 | US6121305 5,5'-dihydroxy-4,4'-bipyrazole compounds of given formula; free radical scavenger; use to treat cerebral ischemia, heart disease, carcinoma, aging, inflammation or digestive system disease, or in detection of an active oxygen or free radicals |
| 09/19/2000 | US6121297 Cyanoguanidines as cell proliferation inhibitors |
| 09/19/2000 | US6121293 Benzothiophene compounds, compositions, and methods |
| 09/19/2000 | US6121292 Methods for reversing multidrug resistance |
| 09/19/2000 | US6121277 Antitumor agents |
| 09/19/2000 | US6121266 Pyridazines as interleukin-1β converting enzyme inhibitors |
| 09/19/2000 | US6121263 Administering synergistic amount of a 1,2,4-benzotriazine-n-oxide derivative prior to administering taxol |
| 09/19/2000 | US6121253 Prostaglandin conjugates for treating or preventing bone disease |
| 09/19/2000 | US6121252 N-acetylated alpha-linked acidic dipeptidase (naaladase) enzyme inhibitors to treat glutamate abnormalities and prostate diseases |
| 09/19/2000 | US6121240 Urokinase receptor ligands |
| 09/19/2000 | US6121047 Antisense modulation of SHP-1 expression |
| 09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners |
| 09/19/2000 | US6121000 Nucleotide sequences; antimetastatis agents; for inhibiting growth of chemotherapy resistant tumors and increasing sensitivity of tumors to chemotherapy |
| 09/19/2000 | US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 09/19/2000 | US6120799 For treatment and diagnosisdiseases and abnormalities such as cancer, wound healing, and chronic inflammatory diseases |
| 09/19/2000 | US6120763 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/19/2000 | CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed |
| 09/19/2000 | CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them |
| 09/14/2000 | WO2000054049A2 Determination of the chemosensitivity via the caspase activity |
| 09/14/2000 | WO2000053776A2 Human kallikrein-like genes |
| 09/14/2000 | WO2000053750A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | WO2000053748A2 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | WO2000053745A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053627A1 METHOD FOR PRODUCING CYCLO-(Asp-DPhe-NMeVal-Arg-Gly) |
| 09/14/2000 | WO2000053626A1 Peptide having an antitumoral, protection and normalisation activity and pharmaceutical composition |
| 09/14/2000 | WO2000053615A1 L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them |
| 09/14/2000 | WO2000053607A1 Camptothecin derivatives having antitumor activity |
| 09/14/2000 | WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders |